Professor Irina Vetter
Professor

Irina Vetter

Email: 
Phone: 
+61 7 334 62660

Background

I am an NHMRC Leadership Fellow with joint apointments at the Institute for Molecular Bioscience (IMB) and School of Pharmacy, UQ. My research interests lie in the fields of peripheral pain mechanisms, target identification and analgesic drug discovery. I investigate the contribution of ion channels to sensory neuronal physiology using highly subtype-selective toxins isolated from venomous animals with the aim to develop novel analgesics with improved efficacy and tolerability.

Availability

Professor Irina Vetter is:
Available for supervision
Media expert

Fields of research

Clinical sciences Neurosciences Pharmacology and pharmaceutical sciences

Qualifications

  • Doctor of Philosophy, The University of Queensland

Research interests

  • Understanding pain pathways

    Pain is a major medical and socio-economic issue affecting one in five Australians. Our research aims to understand the molecular mechanisms behind pain. The current focus of the lab is to use toxins from plants and venomous animals to understand the molecular pharmacology of pain. These toxins are highly selective for ion channels and receptors found in the sensory neurons that detect pain and can potentially be developed into novel analgesics. Our research also investigates the mechanisms contributing to chemotherapy-induced pain, cancer-associated pain, inflammatory and neuropathic pain, and the painful marine toxin disease known as ciguatera. To investigate the neuropharmacology of pain we use a range of techniques including: in vivo pain pathway characterisation, high-content imaging of cultured sensory neurons, high-throughput screening using calcium and membrane potential assays, and traditional pharmacological assays. While all pain has similar symptoms, it is becoming clear that the underlying mechanisms behind pain can vary. Our research has already challenged traditional understanding of pain pathways and sensory neuronal physiology. We work in collaboration with other leading Australian and international researchers to identify novel therapeutic pain pathways and targets. By uncovering these new pain pathways, as well as identifying novel targets on peripheral sensory neurons, we aim to develop more effective pain therapies that treat the underlying cause of the pain, not just the symptoms.

Search Professor Irina Vetter’s works on UQ eSpace

249 works between 2004 and 2024
All (249) Journal Article (196) Book Chapter (13) Conference Publication (39) Other Outputs (1)

161 - 180 of 249 works

2015

Journal Article

Comparative Venomics Reveals the Complex Prey Capture Strategy of the Piscivorous Cone Snail Conus catus

Himaya S.W.A., Jin, Ai-Hua, Dutertre, Sebastien, Giacomotto, Jean, Mohialdeen, Hoshyar, Vetter, Irina, Alewood, Paul F. and Lewis, Richard J. (2015). Comparative Venomics Reveals the Complex Prey Capture Strategy of the Piscivorous Cone Snail Conus catus. Journal of Proteome Research, 14 (10), 4372-4381. doi: 10.1021/acs.jproteome.5b00630

Comparative Venomics Reveals the Complex Prey Capture Strategy of the Piscivorous Cone Snail Conus catus

2015

Journal Article

(-)-Pentylsedinine, a new alkaloid from the leaves of lobelia tupa with agonist activity at nicotinic acetylcholine receptor

Paz, Cristian, Becerra, Jose, Silva, Mario, Burgos, Viviana, Heydenreich, Matthias, Schmidt, Bernd, Thu Tran and Vetter, Irina (2015). (-)-Pentylsedinine, a new alkaloid from the leaves of lobelia tupa with agonist activity at nicotinic acetylcholine receptor. Natural Product Communications, 10 (8), 1355-1357. doi: 10.1177/1934578x1501000810

(-)-Pentylsedinine, a new alkaloid from the leaves of lobelia tupa with agonist activity at nicotinic acetylcholine receptor

2015

Journal Article

Identification and characterization of ProTx-III [μ-TRTX-Tp1a], a new voltage-gated sodium channel inhibitor from venom of the tarantula Thrixopelma pruriens

Cardoso, Fernanda C., Deka, Zoltan, Rosengren, K. Johan, Erickson, Andelain, Vetter, Irina, Deuis, Jennifer R., Herzig, Volker, Alewood, Paul F., King, Glenn F. and Lewis, Richard J. (2015). Identification and characterization of ProTx-III [μ-TRTX-Tp1a], a new voltage-gated sodium channel inhibitor from venom of the tarantula Thrixopelma pruriens. Molecular Pharmacology, 88 (2), 291-303. doi: 10.1124/mol.115.098178

Identification and characterization of ProTx-III [μ-TRTX-Tp1a], a new voltage-gated sodium channel inhibitor from venom of the tarantula Thrixopelma pruriens

2015

Journal Article

δ-Conotoxin SuVIA suggests an evolutionary link between ancestral predator defence and the origin of fish-hunting behaviour in carnivorous cone snails

Jin, Ai-Hua, Israel, Mathilde R., Inserra, Marco, Smith, Jennifer J., Lewis, Richard J., Alewood, Paul F., Vetter, Irina and Dutertre, Sebastien (2015). δ-Conotoxin SuVIA suggests an evolutionary link between ancestral predator defence and the origin of fish-hunting behaviour in carnivorous cone snails. Proceedings of the Royal Society B: Biological Sciences, 282 (1811) 20150817, 1-8. doi: 10.1098/rspb.2015.0817

δ-Conotoxin SuVIA suggests an evolutionary link between ancestral predator defence and the origin of fish-hunting behaviour in carnivorous cone snails

2015

Journal Article

Seven novel modulators of the analgesic target NaV1.7 uncovered using a high-throughput venom-based discovery approach

Klint, Julie K., Smith, Jennifer J., Vetter, Irina, Rupasinghe, Darshani B., Er, Sing Yan, Senff, Sebastian, Herzig, Volker, Mobli, Mehdi, Lewis, Richard J., Bosmans, Frank and King, Glenn F. (2015). Seven novel modulators of the analgesic target NaV1.7 uncovered using a high-throughput venom-based discovery approach. British Journal of Pharmacology, 172 (10), 2445-2458. doi: 10.1111/bph.13081

Seven novel modulators of the analgesic target NaV1.7 uncovered using a high-throughput venom-based discovery approach

2015

Journal Article

Inhibition of N-type calcium channels by fluorophenoxyanilide derivatives

Gleeson, Ellen C., Graham, Janease E., Spiller, Sandro, Vetter, Irina, Lewis, Richard J., Duggan, Peter J. and Tuck, Kellie L. (2015). Inhibition of N-type calcium channels by fluorophenoxyanilide derivatives. Marine Drugs, 13 (4), 2030-2045. doi: 10.3390/md13042030

Inhibition of N-type calcium channels by fluorophenoxyanilide derivatives

2015

Journal Article

α-conotoxin MrIC is a biased agonist at α7 nicotinic acetylcholine receptors

Mueller, Alexander, Starobova, Hana, Inserra, Marco C., Jin, Ai-Hua, Deuis, Jennifer R., Dutertre, Sebastien, Lewis, Richard J., Alewood, Paul F., Daly, Norelle L. and Vetter, Irina (2015). α-conotoxin MrIC is a biased agonist at α7 nicotinic acetylcholine receptors. Biochemical Pharmacology, 94 (2), 155-163. doi: 10.1016/j.bcp.2015.01.011

α-conotoxin MrIC is a biased agonist at α7 nicotinic acetylcholine receptors

2015

Journal Article

A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases

Coll, Rebecca C., Robertson, Avril A. B., Chae, Jae Jin, Higgins, Sarah C., Muñoz-Planillo, Raúl, Inserra, Marco C., Vetter, Irina, Dungan, Lara S., Monks, Brian G., Stütz, Andrea, Croker, Daniel E., Butler, Mark S., Haneklaus, Moritz, Sutton, Caroline E., Núñez, Gabriel, Latz, Eicke, Kästner, Daniel L., Mills, Kingston H. G., Masters, Seth L., Schroder, Kate, Cooper, Matthew A. and O'Neill, Luke A. J. (2015). A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. Nature Medicine, 21 (3), 248-257. doi: 10.1038/nm.3806

A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases

2015

Journal Article

Therapeutic opportunities for targeting cold pain pathways

Yin, Kathleen, Zimmermann, Katharina, Vetter, Irina and Lewis, Richard J. (2015). Therapeutic opportunities for targeting cold pain pathways. Biochemical Pharmacology, 93 (2), 125-140. doi: 10.1016/j.bcp.2014.09.024

Therapeutic opportunities for targeting cold pain pathways

2015

Book Chapter

Venoms-based drug discovery: bioassays, electrophysiology, high-throughput screens and target identification

Vetter, Irina, Hodgson, Wayne C., Adams, David J. and McIntyre, Peter (2015). Venoms-based drug discovery: bioassays, electrophysiology, high-throughput screens and target identification. Venoms to drugs: venom as a source for the development of human therapeutics. (pp. 97-128) edited by Glenn F. King. Cambridge, United Kingdom: Royal Society of Chemistry. doi: 10.1039/9781849737876-00097

Venoms-based drug discovery: bioassays, electrophysiology, high-throughput screens and target identification

2015

Book Chapter

Research methods

Fry, B. G., Undheim, E. A. B., Jackson, T. N. W., Georgieva, D., Vetter, I., Calvete, J. J., Schieb, H., Cribb, B. W., Yang, D. C., Daly, N. L., Manchadi, M. L. Roy, Gutierrez, J. M., Roelants, K., Lomonte, B., Nicholson, G. M., Dziemborowicz, S., Lavergne, V., Ragnarsson, L., Rash, L. D., Mobli, M., Hodgson, W. C., Casewell, N. R., Nouwens, A., Wagstaff, S. C., Ali, S. A., Whitehead, D. L., Herzig, V., Monagle, P., Kurniawan, N. D. ... Sunagar, K. (2015). Research methods. Venomous reptiles and their toxins: evolution, pathophysiology and biodiscovery. (pp. 153-214) New York, NY, United States: Oxford University Press.

Research methods

2015

Journal Article

Vergiftung durch Tropenfisch: Ciguatera-Epidemie in Deutschland

Zimmermann, Katharina, Eisenblätte, Anneka, Vetter, Irina, Ebbecke, Martin, Friedemann, Miriam and Desel, Herbert (2015). Vergiftung durch Tropenfisch: Ciguatera-Epidemie in Deutschland. Deutsche Medizinische Wochenschrift, 140 (2), 125-130. doi: 10.1055/s-0040-100439

Vergiftung durch Tropenfisch: Ciguatera-Epidemie in Deutschland

2015

Conference Publication

Rational development of novel analgesics for the treatment of chronic pain: Structure-Function studies of an engineered Nav1.7 blocker

Rahnama, S., Lachlan, R., Cardoso, F. C., Smith, J., Deuis, J., Vetter, I., King, G. F. and Mobli, M. (2015). Rational development of novel analgesics for the treatment of chronic pain: Structure-Function studies of an engineered Nav1.7 blocker. The 40th Lorne Conference on Protein Structure and Function, Lorne VIC, Australia, 8-12 February 2015.

Rational development of novel analgesics for the treatment of chronic pain: Structure-Function studies of an engineered Nav1.7 blocker

2015

Journal Article

Feeling hot, feeling cold: TRP channels - a great story unfolds

Vetter, Irina, Kym, Philip R. and Szallasi, Arpad (2015). Feeling hot, feeling cold: TRP channels - a great story unfolds. Temperature, 2 (2), 150-151. doi: 10.1080/23328940.2015.1047721

Feeling hot, feeling cold: TRP channels - a great story unfolds

2015

Book Chapter

Seeing the woods for the trees: understanding venom evolution as a guide for biodiscovery

Fry, Bryan G., Koludarov, Ivan, Jackson, Timothy N. W., Holford, Mandë, Terrat, Yves, Casewell, Nicholas R., Undheim, Eivind A. B., Vetter, Irina, Ali, Syed A., Low, Dolyce H. W. and Sunagar, Kartik (2015). Seeing the woods for the trees: understanding venom evolution as a guide for biodiscovery. Venoms to drugs: venom as a source for the development of human therapeutics. (pp. 1-36) edited by Glenn F. King. Cambridge, United Kingdom: Royal Society of Chemistry. doi: 10.1039/9781849737876-00001

Seeing the woods for the trees: understanding venom evolution as a guide for biodiscovery

2015

Journal Article

Transcriptome and proteome of Conus planorbis identify the nicotinic receptors as primary target for the defensive venom

Jin, Ai-Hua, Vetter, Irina, Himaya, Siddhihalu W. A., Alewood, Paul F., Lewis, Richard J. and Dutertre, Sébastien (2015). Transcriptome and proteome of Conus planorbis identify the nicotinic receptors as primary target for the defensive venom. Proteomics, 15 (23-24), 4030-4040. doi: 10.1002/pmic.201500220

Transcriptome and proteome of Conus planorbis identify the nicotinic receptors as primary target for the defensive venom

2015

Book Chapter

Does nature do ion channel drug discovery better than us?

Lewis, Richard J., Vetter, Irina, Cardoso, Fernanda C., Inserra, Marco and King, Glenn (2015). Does nature do ion channel drug discovery better than us?. Ion channel drug discovery. (pp. 297-313) edited by Brian Cox and Martin Gosling. Cambridge, United Kingdom: Royal Society of Chemistry. doi: 10.1039/9781849735087-00297

Does nature do ion channel drug discovery better than us?

2015

Journal Article

α-Conotoxin dendrimers have enhanced potency and selectivity for homomeric nicotinic acetylcholine receptors

Wan, Jingjing, Huang, Johnny X., Vetter, Irina, Mobli, Mehdi, Lawson, Joshua, Tae, Han-Shen, Abraham, Nikita, Paul, Blessy, Cooper, Matthew A., Adams, David J., Lewis, Richard J. and Alewood, Paul F. (2015). α-Conotoxin dendrimers have enhanced potency and selectivity for homomeric nicotinic acetylcholine receptors. Journal of the American Chemical Society, 137 (9), 3209-3212. doi: 10.1021/jacs.5b00244

α-Conotoxin dendrimers have enhanced potency and selectivity for homomeric nicotinic acetylcholine receptors

2014

Journal Article

Design, synthesis and biological evaluation of two opioid agonist and Cav2.2 blocker multitarget ligands

Mollica, Adriano, Costante, Roberto, Novellino, Ettore, Stefanucci, Azzurra, Pieretti, Stefano, Zador, Ferenc, Samavati, Reza, Borsodi, Anna, Benyhe, Sandor, Vetter, Irina and Lewis, Richard J. (2014). Design, synthesis and biological evaluation of two opioid agonist and Cav2.2 blocker multitarget ligands. Chemical Biology and Drug Design, 86 (2), 156-162. doi: 10.1111/cbdd.12479

Design, synthesis and biological evaluation of two opioid agonist and Cav2.2 blocker multitarget ligands

2014

Journal Article

Ciguatera fish poisoning: a first epidemic in Germany highlights an increasing risk for European countries

Mattei, Cesar, Vetter, Irina, Eisenblatter, Anneka, Krock, Bernd, Ebbecke, Martin, Desel, Herbert and Zimmermann, Katharina (2014). Ciguatera fish poisoning: a first epidemic in Germany highlights an increasing risk for European countries. Toxicon, 91 (2), 76-83. doi: 10.1016/j.toxicon.2014.10.016

Ciguatera fish poisoning: a first epidemic in Germany highlights an increasing risk for European countries

Current funding

  • 2024 - 2025
    Super-resolution platform to accelerate biological and molecular research
    ARC Linkage Infrastructure, Equipment and Facilities
    Open grant
  • 2024 - 2027
    Defining a new family of sodium channel accessory proteins
    ARC Discovery Projects
    Open grant
  • 2024 - 2028
    DISCERN - Disciplinary Integration to Solve the Enigma of Chronic Pain: Evaluating Personalised Care and its Impact with Innovative Clinical Trials and Research in Neurobiology, Psychology and Society
    NHMRC Synergy Grants
    Open grant
  • 2023 - 2025
    Studying the basis of and developing new therapies to treat heart disease
    IPF Healthy - Medical Research
    Open grant
  • 2023 - 2026
    Tuning the activating stimulus of voltage-gated sodium channels
    ARC Discovery Projects
    Open grant
  • 2023 - 2027
    Mechanistic and pharmacological insights into peripheral sensory neuron function in physiological and pathological pain
    NHMRC Investigator Grants
    Open grant

Past funding

  • 2024 - 2025
    IL-1RAP: novel target for chemotherapy-induced neuropathy
    Cantargia AB
    Open grant
  • 2022 - 2024
    A humanised sensory neuron high-throughput screening platform
    ARC Linkage Projects
    Open grant
  • 2022 - 2024
    Reducing long-term side-effects of chemotherapy in cancer survivors
    The Kid's Cancer Project
    Open grant
  • 2021 - 2023
    Bivalent analgesics: rational design of selective ion channel inhibitors with optimised mechanism of action
    NHMRC IDEAS Grants
    Open grant
  • 2020
    Electrophysiology Platform for Ion-channel Characterisation
    ARC Linkage Infrastructure, Equipment and Facilities
    Open grant
  • 2020
    New VAST frontiers in non-opioid pain therapies
    VAST Biosciences Pty Ltd
    Open grant
  • 2020 - 2021
    An integrated, multi-node bio-layer interferometry facility
    ARC Linkage Infrastructure, Equipment and Facilities
    Open grant
  • 2020 - 2023
    Mechanism-based treatments for chemotherapy-induced pain
    NHMRC IDEAS Grants
    Open grant
  • 2020 - 2022
    Toxins from Down Under: Novel tools to understand and modulate ion channels
    ARC Discovery Projects
    Open grant
  • 2019 - 2021
    Developing treatments for vincristine-induced neuropathy
    The Kid's Cancer Project
    Open grant
  • 2019 - 2022
    Gain from pain: new tools from venomous animals for exploring pain pathways
    ARC Discovery Projects
    Open grant
  • 2019
    Chemical Purification Network
    UQ Major Equipment and Infrastructure
    Open grant
  • 2019
    In vivo imaging system for tracking inflammation, infection, cancer, pain and bioactive molecules
    UQ Major Equipment and Infrastructure
    Open grant
  • 2019 - 2022
    The role of ion channels in pain pathways
    NHMRC Career Development Fellowship
    Open grant
  • 2019
    Vevo 3100 Imaging System for ultrahigh resolution and frame rate echocardiographic assessment of small animals.
    UQ Major Equipment and Infrastructure
    Open grant
  • 2018 - 2019
    Coagulotoxic effects of Brazilian snake venoms: Role in adaptive evolution and human pathophysiological implications
    UQ-FAPESP Strategic Research Fund SPRINT
    Open grant
  • 2018
    High-throughput ion channel pharmacology
    UQ Major Equipment and Infrastructure
    Open grant
  • 2018
    Multichannel peptide synthesiser to accelerate UQ's biodiscovery pipeline and peptide drug development programs
    UQ Major Equipment and Infrastructure
    Open grant
  • 2018 - 2020
    Novel non-opioid analgesics
    NHMRC Development Grant
    Open grant
  • 2018 - 2020
    Silencing visceral nociceptors by targeting NaV1.1: A novel therapeutic approach for treating Irritable Bowel Syndrome (NHMRC Project Grant led by The Flinders University of South Australia)
    Flinders University
    Open grant
  • 2017 - 2024
    ACRF Cancer Ultrastructure and Function Facility
    Australian Cancer Research Foundation
    Open grant
  • 2017 - 2019
    Novel analgesic approaches: harnessing functional interactions between sodium channels and opioids
    NHMRC Project Grant
    Open grant
  • 2016 - 2018
    The role of Nav1.6 in peripheral pain pathways
    International Association for the Study of Pain
    Open grant
  • 2016
    4D Mass Spectrometer
    UQ Major Equipment and Infrastructure
    Open grant
  • 2016 - 2018
    A pharmacological approach to define the contribution of Nav1.7 to pain pathways
    NHMRC Project Grant
    Open grant
  • 2016
    Establishing a High-Throughput, Microwave-Assisted Automated Peptide Synthesis Facility at PACE
    UQ Major Equipment and Infrastructure
    Open grant
  • 2016
    Integrative blood coagulation research core facility
    UQ Major Equipment and Infrastructure
    Open grant
  • 2016
    Patch-clamp electrophysiology platform for drug and insecticide discovery
    UQ Major Equipment and Infrastructure
    Open grant
  • 2015
    Murine behavioural phenotyping facility
    UQ Major Equipment and Infrastructure
    Open grant
  • 2015
    Protein Analysis Facility
    UQ Major Equipment and Infrastructure
    Open grant
  • 2015
    The assessment of mitochondrial oxygen consumption and cytoplasmic glycolysis in cells to identify and characterize new therapeutic targets for diseases
    UQ Major Equipment and Infrastructure
    Open grant
  • 2015 - 2016
    TRPC5 in teeth - a novel target for tooth pain treatment
    Go8 Australia - Germany Joint Research Co-operation Scheme
    Open grant
  • 2014 - 2018
    Using toxins to understand the mechanisms of pain
    ARC Future Fellowships
    Open grant
  • 2014
    A medium-throughput cell isolation and analysis suite
    UQ Major Equipment and Infrastructure
    Open grant
  • 2013 - 2017
    A VAST potential for ion channel drug discovery
    ARC Linkage Projects
    Open grant
  • 2013 - 2018
    Efficacy Profiling Innovation in Novel Pain Therapeutics Discovery
    ARC Linkage Projects
    Open grant
  • 2013 - 2016
    The role of sodium channels in pain and cold allodynia
    NHMRC Project Grant
    Open grant
  • 2013 - 2014
    Understanding the fundamental molecular basis of sensory perception
    Ramaciotti Foundation
    Open grant
  • 2012 - 2013
    High throughput identification of novel analgesic peptides from cone snail and spider venom
    Queensland Pharmacy Research Trust
    Open grant
  • 2012
    Structure-activity relationship of the novel uO-conotoxin MfVIA
    UQ Early Career Researcher
    Open grant
  • 2012 - 2013
    The pharmacology and molecular mechanisms of ciguatoxin-induced cold allodynia
    Cancer Council Queensland
    Open grant
  • 2011 - 2012
    Development of a mouse model of ciguatoxin-induced cold allodymia to dissect the underlying mechanisms of cold pain
    IASP Early Career Research Grant
    Open grant
  • 2010 - 2011
    Molecular Targets and Mechanisms involved in ciguatoxin-induced cold allodynia
    Go8 Australia - Germany Joint Research Co-operation Scheme
    Open grant
  • 2010 - 2011
    ResTeach 2010 0.1 FTE School of Pharmacy
    Open grant
  • 2009 - 2013
    NHMRC Training Fellowship: Using conesnail venom to better understand chronic pain
    NHMRC Training (Postdoctoral) Fellowship
    Open grant

Availability

Professor Irina Vetter is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

  • Doctor Philosophy

    Discovery and characterisation of multi-valent peptides

    Principal Advisor

    Other advisors: Professor Mehdi Mobli

  • Doctor Philosophy

    Understanding the function of sodium channel accessory proteins to develop new treatments for chronic pain

    Principal Advisor

    Other advisors: Dr Jennifer Deuis, Professor Mehdi Mobli

  • Doctor Philosophy

    Understanding pain mechanisms in the path towards target-specific analgesic agent design

    Principal Advisor

    Other advisors: Dr Ingrid Winkler, Dr Hana Starobova

  • Doctor Philosophy

    Characterization of bivalency in disulfide-rich peptides

    Principal Advisor

    Other advisors: Professor Mehdi Mobli

  • Doctor Philosophy

    Investigating ion channel function and pathology using toxins as tools

    Principal Advisor

    Other advisors: Dr Jennifer Deuis, Dr Angelo Keramidas

  • Master Philosophy

    Using peptide toxins to understand the nociceptor signallosome

    Principal Advisor

    Other advisors: Dr Jennifer Deuis

  • Doctor Philosophy

    Reducing long-term side-effects of chemotherapy in cancer survivors

    Principal Advisor

    Other advisors: Dr Ingrid Winkler, Dr Hana Starobova

  • Doctor Philosophy

    Structure and function of ion channels in pain pathways: a toxin perspective

    Principal Advisor

    Other advisors: Dr Jennifer Deuis

  • Doctor Philosophy

    Developing Models of Cancer Therapy-Induced Late Effects

    Principal Advisor

    Other advisors: Dr Hana Starobova

  • Master Philosophy

    Neuro-immune mechanisms of peripheral neuropathy: a novel target offering new prevention and treatment strategies

    Principal Advisor

    Other advisors: Dr Hana Starobova

  • Doctor Philosophy

    Identification and characterisation of new pain-causing toxins from animal venoms

    Associate Advisor

    Other advisors: Dr Jennifer Deuis, Dr Sam Robinson

  • Doctor Philosophy

    Chemotherapy-induced motor neuropathy: towards improved understanding of motor neuron dysfunction during chemotherapy

    Associate Advisor

    Other advisors: Dr Hana Starobova

  • Doctor Philosophy

    Using toxins as tools to understand sodium channel structure and function

    Associate Advisor

    Other advisors: Dr Jennifer Deuis

  • Doctor Philosophy

    Evolutionary shifts in venom function and chemistry within Bees (Hymenoptera: Apiformes)

    Associate Advisor

    Other advisors: Dr Andrew Walker, Dr Sam Robinson

  • Doctor Philosophy

    New Toxin Tools for Dissecting Pain

    Associate Advisor

    Other advisors: Dr Thomas Durek, Dr Sam Robinson

  • Doctor Philosophy

    Characterization of novel family of voltage-gated sodium channel toxins from ant venoms

    Associate Advisor

    Other advisors: Dr Sam Robinson

  • Doctor Philosophy

    Accessing structurally elusive states of sodium channels as novel analgesic targets

    Associate Advisor

    Other advisors: Dr Thomas Durek, Professor Mehdi Mobli

  • Doctor Philosophy

    Using genomics to predict the mechanism-of-action of a chemical entity

    Associate Advisor

    Other advisors: Associate Professor Sonia Shah

  • Doctor Philosophy

    Identification and characterisation of new pain-causing toxins from animal venoms

    Associate Advisor

    Other advisors: Dr Jennifer Deuis, Dr Sam Robinson

  • Doctor Philosophy

    Probing ion channel function using venom peptides

    Associate Advisor

    Other advisors: Dr Angelo Keramidas

Completed supervision

Enquiries

Contact Professor Irina Vetter directly for media enquiries about:

  • analgesics
  • cancer
  • cancer pain
  • chemotherapy pain
  • chronic pain
  • ciguatera
  • diabetes
  • drug development
  • drug discovery
  • ion channels
  • irritable bowel syndrome
  • neuropathic pain
  • neuropathy
  • neuropharmacology
  • toxins

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au